The $100 million project will include a 40,000-square-foot lab with 36 sterile clean rooms, according to the report. It will employ 150 lab workers when it opens in 2023.
“Medicine is rapidly evolving toward cell- and gene-based therapies,” Steve Davis, MD, president and CEO of Cincinnati Children’s, said in a statement, the Enquirer reported. “This joint venture will ensure that our community, region and the world have ready access to the most innovative and effective therapies.”
The facility could support research on more than 30 clinical trials at once, the statement said. The site hasn’t been chosen yet, but the new facility will be built in the Cincinnati area.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
